메뉴 건너뛰기




Volumn 5, Issue 1, 2011, Pages 745-749

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results

Author keywords

Branch retinal vein occlusion; Central macular thickness; Intravitreal bevacizumab injection; Macular edema; Visual acuity

Indexed keywords

BEVACIZUMAB;

EID: 79958836226     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S19279     Document Type: Article
Times cited : (23)

References (31)
  • 1
    • 33646472759 scopus 로고    scopus 로고
    • Ten-year incidence of retinal vein occlusion in an older population: The Blue Mountain Eye study
    • Cugati S, Wang JJ, Rochtchine E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountain Eye study. Arch Ophthalmol. 2006;124:726-732.
    • (2006) Arch Ophthalmol , vol.124 , pp. 726-732
    • Cugati, S.1    Wang, J.J.2    Rochtchine, E.3    Mitchell, P.4
  • 3
    • 0038388933 scopus 로고    scopus 로고
    • Retinal vein occlusion and hyperhomocysteinemia
    • Blond J, Glacet-Bernard A, Bayani N, et al. Retinal vein occlusion and hyperhomocysteinemia. J Fr Opthalmol. 2003;26:249-253.
    • (2003) J Fr Opthalmol , vol.26 , pp. 249-253
    • Blond, J.1    Glacet-Bernard, A.2    Bayani, N.3
  • 4
    • 0026551575 scopus 로고
    • Risk factors for retinal vein occlusion. A case-control study
    • Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusion. A case-control study. Ophthalmology. 1992;99:509-514.
    • (1992) Ophthalmology , vol.99 , pp. 509-514
    • Rath, E.Z.1    Frank, R.N.2    Shin, D.H.3    Kim, C.4
  • 5
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello L P, Avery RL, Arrig PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
    • (1994) N Engl J Med , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrig, P.G.3
  • 6
    • 0021221946 scopus 로고
    • Argon laser photocoagu-lation for macular edema in branch vein occlusion
    • Branch Retinal Vein Occlusion Study Group
    • Branch Retinal Vein Occlusion Study Group. Argon laser photocoagu-lation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271-282.
    • (1984) Am J Ophthalmol , vol.98 , pp. 271-282
  • 7
    • 23044440795 scopus 로고    scopus 로고
    • Optical cohorence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusion
    • Rosenfeld PJ, Fung AE, Puliafto CA. Optical cohorence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
    • (2005) Ophthalmic Surg Lasers Imaging , vol.36 , pp. 336-339
    • Rosenfeld, P.J.1    Fung, A.E.2    Puliafto, C.A.3
  • 8
    • 26844431631 scopus 로고    scopus 로고
    • Intravitreal triamcinolone compared with macular grid photocoagulation for the treatment of cystoid macular edema
    • Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol. 2005;140:695-702.
    • (2005) Am J Ophthalmol , vol.140 , pp. 695-702
    • Avitabile, T.1    Longo, A.2    Reibaldi, A.3
  • 9
    • 37349021336 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central vein occlusion
    • Karacorlu M, Karacorlu SA, Ozdemir H, et al. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central vein occlusion. Retina. 2007;27:1026-1030.
    • (2007) Retina , vol.27 , pp. 1026-1030
    • Karacorlu, M.1    Karacorlu, S.A.2    Ozdemir, H.3
  • 10
    • 33749602030 scopus 로고    scopus 로고
    • One-year safety and efficacy of intravitreal triamcinolone acetonide for the managment of macular edema secondary to central vein occlusion
    • Gregori NZ, Rosenfeld PJ, Puliafto CA, et al. One-year safety and efficacy of intravitreal triamcinolone acetonide for the managment of macular edema secondary to central vein occlusion. Retina. 2006;26: 889-895.
    • (2006) Retina , vol.26 , pp. 889-895
    • Gregori, N.Z.1    Rosenfeld, P.J.2    Puliafto, C.A.3
  • 11
    • 64849111444 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of prospective clinical trial
    • Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of prospective clinical trial. Br J Ophthalmol. 2009; 93:452-456.
    • (2009) Br J Ophthalmol , vol.93 , pp. 452-456
    • Prager, F.1    Michels, S.2    Kriechbaum, K.3
  • 12
    • 66249083148 scopus 로고    scopus 로고
    • The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion
    • Ahmadi AA, Chuo J Y, Banashkevich A, et al. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion. Can J Ophthalmol. 2009;44:154-159.
    • (2009) Can J Ophthalmol , vol.44 , pp. 154-159
    • Ahmadi, A.A.1    Chuo, J.Y.2    Banashkevich, A.3
  • 13
    • 77949899274 scopus 로고    scopus 로고
    • Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion
    • Kim J Y, Park S P. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol. 2009;23:259-265.
    • (2009) Korean J Ophthalmol , vol.23 , pp. 259-265
    • Kim, J.Y.1    Park, S.P.2
  • 14
    • 73449130129 scopus 로고    scopus 로고
    • Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: A matched study
    • Hou J, Tao Y, Jiang YR, et al. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study. Chin Med J (Eng). 2009;122:2695-2699.
    • (2009) Chin Med J (Eng) , vol.122 , pp. 2695-2699
    • Hou, J.1    Tao, Y.2    Jiang, Y.R.3
  • 15
    • 33646446084 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study
    • Iturradle CB, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006;26:279-284.
    • (2006) Retina , vol.26 , pp. 279-284
    • Iturradle, C.B.1    Spaide, R.F.2    Meyerle, C.B.3
  • 16
    • 37349040676 scopus 로고    scopus 로고
    • Intravitreal bevacizuma (Avastin) in central vein occlusion
    • Hsu J, Kaiser RS, Sivalingam A, et al. Intravitreal bevacizuma (Avastin) in central vein occlusion. Retina. 2007;27:1013-1019.
    • (2007) Retina , vol.27 , pp. 1013-1019
    • Hsu, J.1    Kaiser, R.S.2    Sivalingam, A.3
  • 17
    • 34247231034 scopus 로고    scopus 로고
    • Intravitreal bevaci-zumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
    • Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevaci-zumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419-425.
    • (2007) Retina , vol.27 , pp. 419-425
    • Rabena, M.D.1    Pieramici, D.J.2    Castellarin, A.A.3
  • 18
    • 53849117478 scopus 로고    scopus 로고
    • Treatment of branch retinal vein occlusion induced macular edema with bevacizumab
    • Abegg M, Tappeiner C, Wolf-Schnurrbush U, et al. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol. 2008;8:18.
    • (2008) BMC Ophthalmol , vol.8 , pp. 18
    • Abegg, M.1    Tappeiner, C.2    Wolf-Schnurrbush, U.3
  • 19
    • 77955243577 scopus 로고    scopus 로고
    • Results of bevacizumab as the primary treatment for retinal vein occlusions
    • Figueroa MS, Contreras I, Noval S, Arruabarrena C. Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol. 2010;94:1052-1056.
    • (2010) Br J Ophthalmol , vol.94 , pp. 1052-1056
    • Figueroa, M.S.1    Contreras, I.2    Noval, S.3    Arruabarrena, C.4
  • 20
    • 77951240776 scopus 로고    scopus 로고
    • Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in pair-matched analysis
    • Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in pair-matched analysis. Ophthalmologica. 2010;224:319-324.
    • (2010) Ophthalmologica , vol.224 , pp. 319-324
    • Guthoff, R.1    Meigen, T.2    Hennemann, K.3    Schrader, W.4
  • 21
    • 73349118494 scopus 로고    scopus 로고
    • Comparison of two doses intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: Results of the Pan American Collaborative Retina Study Group at 24 months
    • Wu L, Arevalo JF, Berrocai MH, et al. Comparison of two doses intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. Retina. 2009;29: 1396-1403.
    • (2009) Retina , vol.29 , pp. 1396-1403
    • Wu, L.1    Arevalo, J.F.2    Berrocai, M.H.3
  • 22
    • 71449106064 scopus 로고    scopus 로고
    • Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion
    • Ach T, Hoeh AE, Schaal KB, et al. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2009;247:1635-1641.
    • (2009) Graefes Arch Clin Exp Ophthalmol , vol.247 , pp. 1635-1641
    • Ach, T.1    Hoeh, A.E.2    Schaal, K.B.3
  • 23
    • 33750296920 scopus 로고    scopus 로고
    • The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide
    • Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol. 2006;90:1344-1349.
    • (2006) Br J Ophthalmol , vol.90 , pp. 1344-1349
    • Fung, A.E.1    Rosenfeld, P.J.2    Reichel, E.3
  • 24
    • 77957554417 scopus 로고    scopus 로고
    • Bevacizumab compared with macular laser grid photocoagulation for cystiod macular edema in branch retinal vein occlusion
    • Russo V, Barone A, Conte E, et al. Bevacizumab compared with macular laser grid photocoagulation for cystiod macular edema in branch retinal vein occlusion. Retina. 2010;30:1324-1325.
    • (2010) Retina , vol.30 , pp. 1324-1325
    • Russo, V.1    Barone, A.2    Conte, E.3
  • 25
    • 77957039719 scopus 로고    scopus 로고
    • A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion
    • Cekic O, Cakir M, Yazici AT, et al. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res. 2010;35:925-929.
    • (2010) Curr Eye Res , vol.35 , pp. 925-929
    • Cekic, O.1    Cakir, M.2    Yazici, A.T.3
  • 26
    • 77955390110 scopus 로고    scopus 로고
    • Study of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinolone
    • Rezende M P, Dias AF, Oshima A, et al. Study of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinolone. Arq Bras Oftalmol. 2010;73:129-134.
    • (2010) Arq Bras Oftalmol , vol.73 , pp. 129-134
    • Rezende, M.P.1    Dias, A.F.2    Oshima, A.3
  • 27
    • 42549132257 scopus 로고    scopus 로고
    • Secondary ocular hypertension after intravitreal injection of 4 mg of triam-cinolone acetonide: Incidence and risk factors
    • Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB. Secondary ocular hypertension after intravitreal injection of 4 mg of triam-cinolone acetonide: incidence and risk factors. Retina. 2008;28:573-580.
    • (2008) Retina , vol.28 , pp. 573-580
    • Vasconcelos-Santos, D.V.1    Nehemy, P.G.2    Schachat, A.P.3    Nehemy, M.B.4
  • 28
    • 77955346303 scopus 로고    scopus 로고
    • Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective date from a randomised clinical trial
    • Gillies MC, Islam FM, Larsson J, et al. Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective date from a randomised clinical trial. Clin Experiment Ophthalmol. 2010;38: 605-612.
    • (2010) Clin Experiment Ophthalmol , vol.38 , pp. 605-612
    • Gillies, M.C.1    Islam, F.M.2    Larsson, J.3
  • 29
    • 33847637137 scopus 로고    scopus 로고
    • Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years
    • Islam MS, Vernon SA, Negi A. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years. Eye (Lond). 2007;21:321-323.
    • (2007) Eye (Lond) , vol.21 , pp. 321-323
    • Islam, M.S.1    Vernon, S.A.2    Negi, A.3
  • 30
    • 38349179299 scopus 로고    scopus 로고
    • Aqueous humour of cytocines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion
    • Noma H, Funatsu H, Yamasaki, et al. Aqueous humour of cytocines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond). 2008;22:42-48.
    • (2008) Eye (Lond) , vol.22 , pp. 42-48
    • Noma, H.1    Funatsu, H.2    Yamasaki3
  • 31
    • 33646256581 scopus 로고    scopus 로고
    • Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion
    • Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Exp Ophthalmol. 2006;244:309-315.
    • (2006) Graefes Arch Exp Ophthalmol , vol.244 , pp. 309-315
    • Noma, H.1    Minamoto, A.2    Funatsu, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.